Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients

…, B Jahrsdörfer, H Schrezenmeier, C Ludwig… - Science …, 2021 - science.org
Patients with kidney failure are at increased risk of SARS-CoV-2 infection, making effective
vaccinations a critical need. It is not known how well mRNA vaccines induce B and plasma …

Cell competition is a tumour suppressor mechanism in the thymus

VC Martins, K Busch, D Juraeva, C Blum, C Ludwig… - Nature, 2014 - nature.com
Cell competition is an emerging principle underlying selection for cellular fitness during
development and disease. Competition may be relevant for cancer, but an experimental link …

[HTML][HTML] Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients

…, CL Del Moral, H Schrezenmeier, C Ludwig… - JCI insight, 2022 - ncbi.nlm.nih.gov
Transplant recipients exhibit an impaired protective immunity after SARS-CoV-2 vaccination,
potentially caused by mycophenolate (MPA) immunosuppression. Recent data from …

[HTML][HTML] Robust and durable serological response following pediatric SARS-CoV-2 infection

…, B Tönshoff, GF Hoffmann, B Müller, C Ludwig… - Nature …, 2022 - nature.com
The quality and persistence of children’s humoral immune response following SARS-CoV-2
infection remains largely unknown but will be crucial to guide pediatric SARS-CoV-2 …

Monitoring of antimicrobial susceptibility of respiratory tract pathogens isolated from diseased cattle and pigs across Europe, 2009–2012: VetPath results

…, S Simjee, H Moyaert, U Klein, C Ludwig… - Veterinary …, 2016 - Elsevier
VetPath is an ongoing pan-European antibiotic susceptibility monitoring programme that
collects pathogens from diseased cattle, pigs and poultry. In the current study, 996 isolates from …

[HTML][HTML] B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab

…, H Schrezenmeier, C Ludwig… - Arthritis & …, 2022 - Wiley Online Library
Objective Patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX)
therapy are at higher risk of poor COVID‐19 outcomes and show substantially impaired …

[HTML][HTML] B and T cell responses after a third dose of SARS-CoV-2 vaccine in kidney transplant recipients

…, C Hammett, H Schrezenmeier, C Ludwig… - Journal of the …, 2021 - journals.lww.com
Background Accumulating evidence sugges ts solid organ transplant recipients, as opposed
to the general population, show strongly impaired responsiveness toward standard SARS-…

[HTML][HTML] mRNA vaccines enhance neutralizing immunity against SARS-CoV-2 variants in convalescent and ChAdOx1-primed subjects

D Fabricius, C Ludwig, J Scholz, I Rode, C Tsamadou… - Vaccines, 2021 - mdpi.com
To identify the most efficient methods of immunological protection against SARS-CoV-2,
including the currently most widespread variants of concern (VOCs)—B.1.1.7, B.1.351 and P.1—…

Antimicrobial susceptibility monitoring of bacterial pathogens isolated from urinary tract infections in dogs and cats across Europe: ComPath results

…, A de Jong, F El Garch, U Klein, C Ludwig… - Microbial Drug …, 2017 - liebertpub.com
ComPath is a pan-European antimicrobial surveillance program collecting bacterial
pathogens from dogs and cats not recently exposed to antimicrobials. We present minimum …

Independent side-by-side validation and comparison of 4 serological platforms for SARS-CoV-2 antibody testing

B Jahrsdörfer, J Kroschel, C Ludwig… - The Journal of …, 2021 - academic.oup.com
Highly sensitive and specific platforms for the detection of anti–severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) antibodies are becoming increasingly important for …